EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma

Zhuo Li iD, Linxiu Liu, Bingzhi Wang, Jianming Ying, Jie He, Liyan Xue

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.15043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Zhuo Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor budding (TB) and tumor‐infiltrating lymphocyte (TIL) are significant predictive indicators of lymph node metastasis (LNM) and unfavorable prognosis in various tumors. Currently, there is no gold standard for TB and TIL evaluation in esophageal squamous cell carcinoma (ESCC). This study aimed to identify the standard of TB and TIL evaluations and build a predictive model for prognosis among patients with pT1b ESCC.

Methods

We retrospectively analyzed the prognostic values of TB and TIL in 150 pT1b ESCC cases. Hematoxylin and eosin (H&E) and immunohistochemistry (IHC) of anti‐pan cytokeratin (AE1/AE3) were used to analyze the threshold of TB, and intratumoral TIL and peritumoral TIL (pTIL) were evaluated using the receiver operating characteristic curves (ROC).

Results

We found that TB in a three‐tiered grading system (low‐TB: 0‐4; middle‐TB: 5–15; high‐TB: ≥16) displayed an excellent prognosis prediction for LNM and survival based on IHC staining using a 20× objective lens. Low pTIL level (≤20%) was a significant indicator of LNM and unfavorable prognosis ( p < 0.05). Moreover, lower tumor location and lymphovascular invasion (LVI) were correlated with an unfavorable prognosis ( p < 0.05). A nomogram developed based on TB, pTIL, LVI, and tumor location showed good discrimination, as shown by the area under the ROC and calibration curves.

Conclusion

We therefore recommend identifying TB using a 20× objective lens under IHC staining and TIL adjacent to the tumor. Additionally, a nomogram was built for facilitating individualized prediction of survival for patients with pT1b ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaCarcinoma, Squamous CellEsophageal NeoplasmsHumansLymphocytes, Tumor-InfiltratingRetrospective StudiesNeoplasm InvasivenessPrognosisLymphatic Metastasis

Stichwörter der Autor:innen

lymph node metastasisnomogramprognosistumor buddingtumor infiltrating lymphocyte

Autor:innen und Institutionen

  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Zhuo Li

Zitieren

APA

Li, Z., Liu, L., Wang, B., Ying, J., He, J., & Xue, L. (2023). Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15043

Vancouver

Li Z, Liu L, Wang B, Ying J, He J, Xue L. Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma. Thoracic Cancer. 2023. doi:10.1111/1759-7714.15043

BibTeX
@article{Li2023,
  author = {Li, Zhuo and Liu, Linxiu and Wang, Bingzhi and Ying, Jianming and He, Jie and Xue, Liyan},
  title = {Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.15043}
}
Kostenlos starten →